Evidence map›Paper›PMID 38471525›Full record

ArticlePharmacopsychiatry2024

Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany.

Natalia Szejko, Eva Becher, Florian Heimann, Franjo Grotenhermen, Kirsten R Müller-Vahl

Open access · hybridAbstract read
In one paragraph

Article in Pharmacopsychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Natalia SzejkoClinic of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
Eva BecherDepartment of Sex- and Gender-specific Medicine, University of Bielefeld, Bielefeld, Germany.
Florian HeimannCannabis-Apotheke.de, Apotheke LUX99, Hürth, Germany.
Franjo GrotenhermenInternational Association for Cannabinoid Medicines, Steinheim, Germany.
Kirsten R Müller-VahlClinic of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
Bielefeld University · DEMedizinische Hochschule Hannover · DEPost Apotheke · DEUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUp to now, it is unclear whether different medicinal

methodsThis was an online survey conducted in Germany between June 2020 and August 2020. Patients were allowed to participate only if they received a

resultsThe survey was completed by n=1,028 participants. Most participants (58%) have used MC for more than 1 year, on average, 5.9 different strains.

conclusionsPatients self-reported very good efficacy and tolerability of MC. There was no evidence suggesting that specific MC strains are superior depending on the disease to be treated.

Indexed as

Medical MarijuanaAdolescentAdultAgedCannabidiolCannabisDronabinolFemaleGermanyHumansMaleMiddle AgedProspective StudiesSurveys and QuestionnairesTreatment OutcomeYoung AdultCannabidiolDronabinolMedical Marijuana

Identifiers

PMID38471525
PMCPMC11076101
OpenAlexW4394755651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.